The Brown University Geriatric Psychopharmacology Update articles from March 2007

The Brown University Geriatric Psychopharmacology Update archives from March 2007

UK study: no correlation between antipsychotic use and cognitive decline in AD patients.(Results From Laser-AD Longitudinal Study)(Alzheimer's Disease)(Clinical report)
March 1, 2007... precis * AD patients taking atypical antipsychotics may be no more likely to experience cognitive decline than AD patients not taking atypicals * Results from the London and South-East Region Alzheimer's Disease (LASER-AD) study of an...

AAGP issues position statement on principles of care for dementia resulting from Alzheimer's disease.(Alzheimer's Disease)(American Association for Geriatric Psychiatry)
March 1, 2007... precis * There currently exists a systematic and effective care treatment model for patients with dementia resulting from AD whose pharmacologic and nonpharmacologic interventions have been shown to produce benefits for patients and...

Duloxetine and a case of hyponatremia.(Adverse Events)(Clinical report)
March 1, 2007... Hyponatremia associated with the use of a selective serotonin reuptake inhibitor (SSRI), (1) venlafaxine (Effexor), (2) or reboxetine, (3) a selective norepinephrine reuptake inhibitor (SNRI) not available in USA, has been reported in the...

Non-significant mortality increase in risperidone-treated dementia patients.(What's New in Research)(Clinical report)
March 1, 2007... precis * A meta-analysis of 6 double-blind, placebo-controlled trials indicate that risperidone-treatment of psychosis or behavioral and psychological symptoms of dementia in the elderly resulted in a non-significant increase in mortality...

Relation between folate intake and risk of Alzheimer's disease.(What's New in Research)(Clinical report)
March 1, 2007... precis * Higher folate intake was found to be related to lower risk of Alzheimer's disease (AD) in a cohort of predominantly Caribbean Hispanic and African American elderly subjects with a high prevalence of vascular risk factors; intake...

Intravenous lidocaine for treatment-resistant verbal hallucinations.(Case Reports)(Clinical report)
March 1, 2007... Patient: Female, 74 y/o Medications: Carbamazepine (Carbatrol, Equetro, Tegretol), lidocaine (Xylocaine), antipsychotics (unspecified), antidepressants (unspecified) Comments: A 74-year-old woman with mild depression had a 5-year...

Off-label use of atypical antipsychotics.(News Notes)(Brief article)
March 1, 2007... Evidence is lacking to support many of the off-label uses of atypical antipsychotics, according to a report by the Agency for Healthcare Research and Quality's (AHRQ) Southern California/ RAND Evidence-based Practice Center. The most common...

First-time generic approval of ondansetron (Zofran).(From the FDA)(Kali Laboratories)(Brief article)
March 1, 2007... Final approval has been granted (December 27, 2006) for a first generic version of Zofran (ondansetron) tablets, orally disintegrating tablets, and oral solution. Ondansetron is indicated for the prevention of nausea and vomiting associated...

Zyprexa (brand).(YOUR MEDICATION INFORMATION)(Drug overview)
March 1, 2007... Olanzapine (generic) Classification: Atypical antipsychotic; mood stabilizer. Common Usage: Oral olanzapine has FDA-approved indications for the treatment of schizophrenia and for the short-term treatment of acute manic or mixed...